We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$758M
AUM Growth
+$10.8M
Cap. Flow
-$14.1M
Cap. Flow %
-1.86%
Top 10 Hldgs %
25.76%
Holding
210
New
11
Increased
76
Reduced
102
Closed
7

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.43M
2
V icon
Visa
V
+$1.2M
3
WFM
Whole Foods Market Inc
WFM
+$1.18M
4
RL icon
Ralph Lauren
RL
+$960K
5
CTSH icon
Cognizant
CTSH
+$891K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$5.96M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$2.44M
3
XOM icon
ExxonMobil
XOM
+$2.29M
4
ABBV icon
AbbVie
ABBV
+$2.07M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 22.8%
2 Energy 11.9%
3 Industrials 11.23%
4 Consumer Staples 10.78%
5 Technology 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIAL
26
DELISTED
SIGMA - ALDRICH CORP
SIAL
$7.87M 1.04%
77,509
+6,580
+9% +$639K
ITW icon
27
Illinois Tool Works
ITW
$82.1B
$7.72M 1.02%
88,206
+1,345
+2% +$116K
RTX icon
28
RTX Corp
RTX
$289B
$7.65M 1.01%
105,306
-6,285
-6% -$463K
COST icon
29
Costco
COST
$422B
$7.43M 0.98%
64,554
+914
+1% +$105K
GILD icon
30
Gilead Sciences
GILD
$162B
$7.34M 0.97%
88,497
-114
-0.1% -$8.87K
JPM icon
31
JPMorgan Chase
JPM
$940B
$7.04M 0.93%
122,237
-3,566
-3% -$200K
UL icon
32
Unilever
UL
$138B
$6.89M 0.91%
135,144
+2,412
+2% +$121K
ROST icon
33
Ross Stores
ROST
$80.7B
$6.76M 0.89%
204,338
+15,510
+8% +$532K
DHR icon
34
Danaher
DHR
$137B
$6.75M 0.89%
127,582
+9,131
+8% +$469K
V icon
35
Visa
V
$680B
$6.71M 0.89%
127,468
+23,020
+22% +$1.2M
RPM icon
36
RPM International
RPM
$13.6B
$6.55M 0.86%
141,903
-9,636
-6% -$417K
MCD icon
37
McDonald's
MCD
$192B
$6.33M 0.83%
62,812
-1,040
-2% -$105K
IJR icon
38
iShares Core S&P Small-Cap ETF
IJR
$109B
$6.32M 0.83%
112,766
-34,730
-24% -$1.88M
CB
39
DELISTED
CHUBB CORPORATION
CB
$6.26M 0.83%
67,956
-17
-0% -$1.56K
CL icon
40
Colgate-Palmolive
CL
$73.2B
$6.2M 0.82%
90,938
+10,280
+13% +$689K
VIG icon
41
Vanguard Dividend Appreciation ETF
VIG
$111B
$6.19M 0.82%
79,369
+11,366
+17% +$869K
ORCL icon
42
Oracle
ORCL
$364B
$6.15M 0.81%
151,844
+6,324
+4% +$260K
NEE icon
43
NextEra Energy
NEE
$183B
$6.09M 0.8%
237,760
-4,304
-2% -$105K
CVX icon
44
Chevron
CVX
$388B
$6M 0.79%
45,918
-2,087
-4% -$260K
CTSH icon
45
Cognizant
CTSH
$24.4B
$5.83M 0.77%
119,291
+18,286
+18% +$891K
MMP
46
DELISTED
Magellan Midstream Partners, L.P.
MMP
$5.66M 0.75%
67,355
-2,640
-4% -$207K
NKE icon
47
Nike
NKE
$61.8B
$5.59M 0.74%
144,070
-2,362
-2% -$87.9K
NVO
48
Novo Nordisk
NVO
$208B
$5.39M 0.71%
233,460
-6,730
-3% -$149K
IJH icon
49
iShares Core S&P Mid-Cap ETF
IJH
$122B
$5.16M 0.68%
180,275
-88,955
-33% -$2.44M
VZ icon
50
Verizon
VZ
$195B
$5.14M 0.68%
105,046
+1,052
+1% +$51K
1
2
3 4 5

Similar funds

CANY
Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Boston Financial Management's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Financial Management held 210 positions worth $758M, up 1.5% from $747M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Boston Financial Management's Q2 2014 filing shows 11 new, 76 increased, 102 reduced and 7 closed positions. Its largest new stake was Theravance Biopharma: 16,982 shares worth $541K. The largest sale was IBM, an estimated $5.96M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Energy and Industrials.

  • Boston Financial Management's largest Q2 2014 buy was Theravance Biopharma: 16,982 shares worth $541K.
  • Boston Financial Management added most to Berkshire Hathaway Class B in Q2 2014, an estimated $1.43M increase.
  • Boston Financial Management's biggest Q2 2014 reduction was IBM, cutting an estimated $5.96M.
  • Boston Financial Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2014, selling an estimated $1.38M.
  • Boston Financial Management's ten largest holdings make up 26% of its $758M portfolio in Q2 2014.
  • Boston Financial Management opened 11 new positions and closed 7 in Q2 2014.
  • Boston Financial Management's portfolio value rose 1.5% quarter-over-quarter to $758M.

Based on Boston Financial Management's 13F filing for Q2 2014, filed 20 Aug 2014.